| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 80.0 | ¤46,714 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 66.4 | ¤15,226 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 55.3 | ¤8,574 | CN |
| 688336.CN | Sunshine Guojian Pharmaceutical (Shangha | 86.0 | ¤6,631 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 91.3 | ¤6,311 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300515.CN | Hunan Sundy Science and Technology Co., | 72.2 | ¤498 | CN |
| 603309.CN | WELL LEAD MEDICAL CO LTD Class A | 48.9 | ¤595 | CN |
| 300871.CN | Hvsen Biotechnology Co. Ltd. Class A | 66.7 | ¤772 | CN |
| 688410.CN | SWS Hemodialysis Care Co., Ltd. Class A | 57.4 | ¤798 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 52.0 | ¤990 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 66.4 | 20 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 70.7 | 19 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 52.0 | 11 | CN |
| 300357.CN | Zhejiang Wolwo Bio-Pharmaceutical Co., L | 63.9 | 11 | CN |
| 000963.CN | Huadong Medicine Co., Ltd. Class A | 55.3 | 10 | CN |
| 600750.CN | China Resources Jiangzhong Pharmaceutica | 55.4 | 10 | CN |
| 600211.CN | Tibet Rhodiola Pharmaceutical Holding Co | 63.6 | 9 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 71.9 | 9 | CN |
| 688278.CN | Xiamen Amoytop Biotech Co., Ltd. Class A | 71.1 | 7 | CN |
| 002773.CN | Chengdu Kanghong Pharmaceutical Group Co | 45.9 | 6 | CN |
| Average Market Cap | ¤4,550 |
| Median Market Cap | ¤1,964 |
| Avg. 3 Mo. Dollar Vol. | ¤46,827,515 |
| Avg. 3 Mo. Trading Vol. | 7,095,719 |
| Last Rebalance Date | 12/22/2025 |
| Companies Replaced | 15 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 21.1 |
| Forward P/E Ratio (12 Mo.) | 15.1 |
| Price/Book Ratio | 3.5 |
| Avg. Revenue Chg. - 3 Yr | 59.9% |
| Avg. Op. Income Chg. - 3 Yr. | 102.5% |
| Avg. EPS Growth - 3 Yr. | 27.8% |
| Avg. EPS Growth - 1 Yr. | 17.8% |
| Avg. Operating Margin | 25.6% |
| Avg. LT Debt to Total Capital | 4.9% |
| Avg. Return on Equity | 15.8% |
| Dividend Yield | 1.8% |
| China Health Care Index | 63.93 |
| China | 100.0% |
